Literature DB >> 14611838

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.

Hitoshi Hotoda1, Miyuki Furukawa, Makiko Daigo, Kazuhiro Murayama, Masakatsu Kaneko, Yasunori Muramatsu, Michiko Miyazawa Ishii, Shun-ichi Miyakoshi, Toshio Takatsu, Masatoshi Inukai, Masayo Kakuta, Tomomi Abe, Tamako Harasaki, Takashi Fukuoka, Yukio Utsui, Satoshi Ohya.   

Abstract

Capuramycin analogues with a variety of substituents in place of the azepan-2-one moiety were synthesized from A-500359E and were tested for their translocase I inhibitory activity and in vitro antimycobacterial activity. Phenyl-type moieties were found to be effective substituents for capuramycin analogues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611838     DOI: 10.1016/s0960-894x(03)00596-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Chemical modification of capuramycins to enhance antibacterial activity.

Authors:  Elena Bogatcheva; Tia Dubuisson; Marina Protopopova; Leo Einck; Carol A Nacy; Venkata M Reddy
Journal:  J Antimicrob Chemother       Date:  2010-12-23       Impact factor: 5.790

2.  A biocatalytic approach to capuramycin analogues by exploiting a substrate permissive N-transacylase CapW.

Authors:  Xiaodong Liu; Yuanyuan Jin; Wenlong Cai; Keith D Green; Anwesha Goswami; Sylvie Garneau-Tsodikova; Koichi Nonaka; Satoshi Baba; Masanori Funabashi; Zhaoyong Yang; Steven G Van Lanen
Journal:  Org Biomol Chem       Date:  2016-04-06       Impact factor: 3.876

Review 3.  Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.

Authors:  Vadim Makarov; Elena Salina; Robert C Reynolds; Phyo Phyo Kyaw Zin; Sean Ekins
Journal:  J Med Chem       Date:  2020-04-20       Impact factor: 7.446

Review 4.  Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.

Authors:  Stephanie Sibinelli-Sousa; Julia Takuno Hespanhol; Ethel Bayer-Santos
Journal:  J Bacteriol       Date:  2021-03-08       Impact factor: 3.490

5.  The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.

Authors:  Wenlong Cai; Anwesha Goswami; Zhaoyong Yang; Xiaodong Liu; Keith D Green; Sandra Barnard-Britson; Satoshi Baba; Masanori Funabashi; Koichi Nonaka; Manjula Sunkara; Andrew J Morris; Anatol P Spork; Christian Ducho; Sylvie Garneau-Tsodikova; Jon S Thorson; Steven G Van Lanen
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

6.  DPAGT1 Inhibitors of Capuramycin Analogues and Their Antimigratory Activities of Solid Tumors.

Authors:  Katsuhiko Mitachi; Rita G Kansal; Kirk E Hevener; Cody D Gillman; Syed M Hussain; Hyun Gi Yun; Gustavo A Miranda-Carboni; Evan S Glazer; William M Clemons; Michio Kurosu
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

7.  A reliable Pd-mediated hydrogenolytic deprotection of BOM group of uridine ureido nitrogen.

Authors:  Bilal A Aleiwi; Michio Kurosu
Journal:  Tetrahedron Lett       Date:  2012-05-12       Impact factor: 2.415

Review 8.  Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.

Authors:  Ellene H Mashalidis; Seok-Yong Lee
Journal:  J Mol Biol       Date:  2020-03-19       Impact factor: 5.469

9.  Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis.

Authors:  Boris Nikonenko; Venkata M Reddy; Elena Bogatcheva; Marina Protopopova; Leo Einck; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

10.  Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.

Authors:  Boris V Nikonenko; Venkata M Reddy; Marina Protopopova; Elena Bogatcheva; Leo Einck; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.